Conor Murphy

Dr. Conor Murphy

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2020 in Annals of Surgery
Verified
Journal Article
Closed access
CMConor Murphy
Conor Murphy
TDTalulla Dunne
Talulla Dunne
JEJessie A Elliott
Jessie A Elliott
SKSivesh Kamarajah
Sivesh Kamarajah
JLJames Mbbs Leighton
James Mbbs Leighton
JRJohn V. Md Reynolds
John V. Md Reynolds
Objective: To determine the incidence, risk factors, and consequences of AKI in patients undergoing surgery for esophageal cancer Summary of Background Data: Esophageal cancer surgery is an exemplar of major operative trauma, with well-defined risks of respiratory, cardiac, anastomotic, and septic complications. However, there is a paucity of literature regarding AKI. Methods: consecutive patients undergoing curative-intent surgery for esophageal cancer from 2011 to 2017 in 3 high-volume centers were studied. AKI was defined according to the AKI Network criteria. AKI occurred if, within 48 hours postoperatively, serum creatinine rose by 50% or by 0.3 mg/dL (26.5 μmol/L) from preoperative baseline. Complications were recorded prospectively. Multivariable logistic regression determined factors independently predictive of AKI. Results: A total of 1135 patients (24.7%:75.3% female:male, with a mean age of 64, a baseline BMI of 27 kg m−2, and dyslipidemia in 10.2%), underwent esophageal cancer surgery, 85% having an open thoracotomy. Overall in-hospital mortality was 2.1%. Postoperative AKI was observed in 208 (18.3%) patients, with AKI Network 1, 2, and 3 in 173 (15.2%), 28 (2.5%), and 7 (0.6%), respectively. Of these, 70.3% experienced improved renal function within 48 hours. Preoperative factors independently predictive of AKI were age [P = 0.027, odds ratio (OR) 1.02 (1.00–1.04)], male sex [P = 0.015, OR 1.77 (1.10–2.81)], BMI at diagnosis [P < 0.001, OR 1.10 (1.07–1.14)], and dyslipidemia [P = 0.002, OR 2.14 (1.34–3.44)]. Postoperatively, AKI was associated with atrial fibrillation (P = 0.013) and pneumonia (P = 0.005). Postoperative AKI did not impact survival outcomes. Conclusion: AKI is common but mostly self-limiting after esophageal cancer surgery. It is associated with age, male sex, increased BMI, dyslipidemia, and postoperative morbidity.

9 January 2019 in Archives of Osteoporosis
Verified
Journal Article
Closed access
PDF file
JEJessie A Elliott
Jessie A Elliott
SCSean Casey
Sean Casey
CMConor Murphy
Conor Murphy
Neil G. DochertyNeil G. Docherty
Neil G. Docherty
NRNarayanasamy Ravi
Narayanasamy Ravi
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux

9 July 2020 in Annals of Surgery
Verified
Journal Article
Closed access
NDNoel Donlon
Noel Donlon
JEJessie A Elliott
Jessie A Elliott
CDClaire L Donohoe
Claire L Donohoe
CMConor Murphy
Conor Murphy
TNTim Nugent
Tim Nugent
JRJohn V. Reynolds
John V. Reynolds
Objective: The aim of this study was to propose and test a novel adverse pathology classification in AEG. Background: Recent scientific advances show genomic and molecular concordance across all AEG types, suggesting a rationale for a biologic classification. We tested a 3-dimension adverse pathology classification across the entire junction and per Siewert anatomic subtype. Methods: Of 1625 patients with AEG, 650 underwent radical surgery, 55% post-neoadjuvant therapy (NeoT). Adverse features defined a priori were poor differentiation (PD), lymphatic invasion (LI), vascular invasion (VI), and perineural invasion (PN), with 3 groupings: 0 (no adverse feature), 1 to 2, and 3 to 4. Multivariable logistic and Cox proportional hazards regression were applied. Results: For adverse pathology, 31%, 46%, and 23% had 0, 1 to 2, and 3 to 4, respectively. Fifty percent of cases were AEG I, 25% AEG II, and 25% AEG III. Median survival was not reached, 49 and 17 months for 0, 1 to 2, and 3 to 4 adverse pathology, respectively (P < 0.001), and 76, 51, and 34 months for AEG I, II, and III, respectively (P < 0.001); AEG I was significantly (P< 0.001) associated with lower c (y)pT and c (y)pN stages, and LI, VI, PN, and PD (poor vs other). The pathology model was significant for survival along with (y)pT and (y)pN, and predicted response to chemotherapy and chemoradiation irrespective of anatomic subtype (P < 0.001). Conclusion: A novel classification using standard pathology as proxy for poor biology is associated with survival and response to therapy. This effect is observed across the entire AEG spectrum, highlighting how biology should be aligned with anatomy in the modern paradigm of AEG management and design of clinical trials.

1 February 2022 in Clinical Nutrition Open Science
Verified
Journal Article
Open access
SBSarah Bennett
Sarah Bennett
CMConor Murphy
Conor Murphy
MFMichelle Fanning
Michelle Fanning
JRJohn V. Reynolds
John V. Reynolds
SDSuzanne L. Doyle
Suzanne L. Doyle
CDClaire L Donohoe
Claire L Donohoe

22 June 2020 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
CMConor Murphy
Conor Murphy
MFMichelle Fanning
Michelle Fanning
NRNicola Raftery
Nicola Raftery
JEJessie A Elliott
Jessie A Elliott
NDNeil G Docherty
Neil G Docherty
JRJohn V Reynolds
John V Reynolds
Improved cure rates in esophageal cancer care have increased focus on health-related quality of life (HRQL) in survivorship. To optimize recovery after esophagectomy, particularly nutritional well-being, a personalized multidisciplinary survivorship clinic was established at this center. Assessments at 6 and 12 months postoperatively include validated European Organization for the Research and Treatment of Cancer (EORTC) symptom and health-related quality of life (HRQL) questionnaires, functional status review, anthropometry, and biochemical screening for micronutrient deficiencies. 75 patients, at a mean age of 63 years, 84% male, 85% with adenocarcinoma, and 73% receiving multimodal therapy were included. Mean preoperative body mass index (BMI) was 27.5 (4.3) kg m −2. 6- and 12-month assessments were completed by 66 (88%) and 37 (93%) recurrence-free patients, respectively. Mean body weight loss at 6 months was 8.5 ± 6.6% and at 12 months 8.8 ± 7.3%. Of the 12-month cohort, micronutrient deficiency was present in 27 (79.4%) preoperatively and 29 (80.6%) after 1 year (P = 0.727), most commonly iron deficiency (preoperative: 16 [43.2%] and postoperative: 17 [45.9%] patients, P = 0.100). 26 (70.3%) of these patients also had clinically significant dumping syndrome persisting to 12 months after surgery. We describe a novel follow-up support structure for esophageal cancer patients in the first year of survivorship. This may serve as an exemplar model with parallel application across oncological care.

18 September 2020 in Diseases of the Esophagus
Verified
Journal Article
Closed access
PDF file
CMConor Murphy
Conor Murphy
JEJ A Elliott
J A Elliott
NDN G Docherty
N G Docherty
AMA A Mohamed
A A Mohamed
RVRoyce Vincent
Royce Vincent
Carel W. Le RouxCarel W. Le Roux
Carel W. Le Roux
Esophagectomy causes postprandial symptoms associated with an exaggerated postprandial gut hormone response. This study aimed to compare the gastrointestinal transit time of patients 1 year after esophagectomy with unoperated controls, including its relation to satiety gut hormone release. In this cross-sectional study, consecutive, disease-free patients after esophagectomy with pyloroplasty were compared with unoperated control subjects to assess gastric emptying (GE) and cecal arrival time (CAT). Serial plasma samples were collected before, and for 300 minutes after, a mixed-meal challenge. Body composition was assessed, and symptom scores were calculated. Eleven patients 1 year post-esophagectomy (age: 62.6 ± 9.8, male: 82%) did not show a significantly different GE pattern compared with 10 control subjects (P = 0.245). Rather, patients could be categorized bimodally as exhibiting either rapid or slow GE relative to controls. Those with rapid GE trended toward a higher postprandial symptom burden (P = 0.084) without higher postprandial glucagon-like peptide-1 (GLP-1) secretion (P = 0.931). CAT was significantly shorter after esophagectomy (P = 0.043) but was not significantly associated with GE, GLP-1 secretion, or symptom burden. Neither early nutrient delivery to the proximal small intestine nor to the colon explains the exaggerated postprandial GLP-1 response after esophagectomy. GE varies significantly in these patients despite consistent pyloric management.